2008 Quarterly Results
| 1st Quarter - | Axcan Pharma Reports Solid Start to Fiscal 2008, With Revenue of $92.9 Million in the First Quarter
MD&A (PDF 0.411 MB) and |
Isabelle Adjahi
Senior Director, Investor Relations and Communications
Axcan Pharma Inc.
597, Laurier Blvd.
Mont-Saint-Hilaire, QC., J3H 6C4
Canada